Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight

作者: Jeroen Alphons Dorothea Maria Tonnaer

DOI:

关键词: PediatricsRisk factorDiseasePsychiatryWeight increasingAntipsychotic AgentWeight gainSchizophreniaOverweightMedicineAsenapine

摘要: The invention provides means for the treatment of schizophrenia with an antipsychotic agent administered to a patient overweight, or that was having weight gain due agent, needs be protected against increase presence risk factors disease which overweight is also factor other increasing by using asenapine manufacture medicine such treatment.

参考文章(11)
Olivier Blin, Joëlle Micallef, Antipsychotic-associated weight gain and clinical outcome parameters. The Journal of Clinical Psychiatry. ,vol. 62, pp. 11- 21 ,(2001)
Shishuka Malhotra, Susan L. McElroy, Medical management of obesity associated with mental disorders. The Journal of Clinical Psychiatry. ,vol. 63, pp. 24- 32 ,(2002)
Roger S McIntyre, Sonia M McCann, Sidney H Kennedy, Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. The Canadian Journal of Psychiatry. ,vol. 46, pp. 273- 281 ,(2001) , 10.1177/070674370104600308
Norman Sussman, Review of atypical antipsychotics and weight gain. The Journal of Clinical Psychiatry. ,vol. 62, pp. 5- 12 ,(2001)
Daniel E. Casey, Stevin H. Zorn, The pharmacology of weight gain with antipsychotics. The Journal of Clinical Psychiatry. ,vol. 62, pp. 4- 10 ,(2001)
Joseph C. Cappelleri, Janet L. Mentore, Ming C. Infante, Linda P. Chandler, David B. Allison, Moonseong Heo, Peter J. Weiden, Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis American Journal of Psychiatry. ,vol. 156, pp. 1686- 1696 ,(1999) , 10.1176/AJP.156.11.1686
Johannes Hubertus Wieringa, Leonardus Petrus Carla Delbressine, Sublingual or buccal pharmaceutical composition ,(1995)
Maria C. Alexander-Bridges, Hui-Fen Zhao, Inhibition of insulin-induced adiposis ,(1994)